511509 VIVOBIOT

Vivo Bio Tech Share Price

 

 

Start SIP in VIVOBIOT

Start SIP

Performance

  • Low
  • ₹32
  • High
  • ₹34
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹57
  • Open Price₹33
  • Previous Close₹33
  • Volume21,795

Investment Returns

  • Over 1 Month + 5.18%
  • Over 3 Month -13.8%
  • Over 6 Month -13.8%
  • Over 1 Year -13.27%

Smart Investing Starts Here Start SIP with Vivo Bio Tech for Steady Growth!

Invest Now

Vivo Bio Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.7
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 52
  • P/B Ratio
  • 0.6
  • Average True Range
  • 2.04
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.52
  • RSI
  • 56.17
  • MFI
  • 71.12

Vivo Bio Tech Financials

Vivo Bio Tech Technicals

EMA & SMA

Current Price
₹32.10
-0.5 (-1.53%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹30.61
  • 50 Day
  • ₹31.79
  • 100 Day
  • ₹33.53
  • 200 Day
  • ₹35.33

Resistance and Support

32.46 Pivot Speed
  • R3 34.89
  • R2 34.20
  • R1 33.15
  • S1 31.41
  • S2 30.72
  • S3 29.67

Vivo Bio Tech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-12 Quarterly Results
2025-05-19 Audited Results
2025-01-09 Quarterly Results
2024-11-21 Employees Stock Option Plan

Vivo Bio Tech F&O

Vivo Bio Tech Shareholding Pattern

35.16%
32.3%
32.54%

Vivo Bio Tech FAQs

Vivo Bio Tech share price is ₹32 As on 30 December, 2025 | 01:27

The Market Cap of Vivo Bio Tech is ₹51.8 Cr As on 30 December, 2025 | 01:27

The P/E ratio of Vivo Bio Tech is 12.7 As on 30 December, 2025 | 01:27

The PB ratio of Vivo Bio Tech is 0.6 As on 30 December, 2025 | 01:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23